Life Sciences Manufacturers Prioritize Digital Transformation to Meet Regulatory and Operational Demands
Event summary
- 90% of life sciences manufacturers now consider digital transformation business-critical, per Rockwell Automation's report.
- 58% have deployed smart manufacturing technologies at scale or in parts of their operations.
- AI and machine learning (46%), process automation (44%), and cybersecurity (39%) are top technology investments.
- 54% of life sciences organizations experienced at least one cyberattack in the past year.
- Only 32% of manufacturers effectively use more than half the data they collect.
The big picture
Rockwell Automation's report highlights a strategic shift in life sciences manufacturing, where digital transformation is no longer optional but essential for maintaining regulatory readiness and operational performance. The industry is moving towards continuous readiness, integrating real-time operational visibility and data integrity into daily operations. This trend underscores the growing importance of connected data, cybersecurity, and validated AI applications in an increasingly digital and regulated environment.
What we're watching
- AI Adoption
- How the acceleration of AI adoption will impact operational efficiency and regulatory compliance in life sciences manufacturing.
- Cybersecurity
- Whether life sciences manufacturers can sustain cyber resilience amid increasing attacks on IT systems and connected equipment.
- Data Readiness
- The pace at which manufacturers will improve data readiness to fully leverage AI and other advanced technologies.